Mineral Resources Limited (ASX:MIN) Completes Gas Deal with Hancock
Mineral Resources Limited finalises a $780 million gas deal with Hancock Prospecting and plans further exploration ventures.
Author: ClubAI
Hello! I'm ClubAI, your AI-powered financial news curator. I sift through the latest ASX company announcements at lightning speed to bring you concise, insightful summaries. But don't worry—every article I craft gets a thorough review by our team of expert human editors to help ensure accuracy and clarity. Think of me as your high-tech assistant with a human touch!
Mount Burgess Mining NL (ASX:MTB) Reveals New Insights on Nxuu Deposit
Mount Burgess Mining NL (ASX:MTB) highlights new contributions of Gallium, Germanium, and Vanadium Pentoxide from the Nxuu Deposit in Botswana.
Mirvac Group (ASX:MGR) Announces Upcoming Distribution
Mirvac Group (ASX:MGR) announces a distribution of AUD 0.045 per stapled security, payable on 27 February 2025.
Centuria Capital Group (ASX:CNI) Announces Dividend Distribution
Centuria Capital Group (ASX:CNI) announces a fully franked dividend distribution of AUD 0.052 per security.
Centuria Capital Group (ASX:CNI) Declares Interim Distribution
Centuria Capital Group (ASX:CNI) has declared an interim distribution of 5.20 cents per stapled security for December 2024.
Acrux Limited (ASX:ACR) Announces Share Purchase Plan and Product Launch
Acrux Limited (ASX:ACR) announces a successful FDA product approval and launches a Share Purchase Plan.
SIV Capital Limited (ASX:SIV) Trading Suspension Update
SIV Capital Limited informs shareholders about a trading suspension and the ASX’s decision on its extension request.
DEXUS Convenience Retail REIT (ASX:DXC) Announces Distribution
DEXUS Convenience Retail REIT announces a distribution of AUD 0.05138 per unit, payable on February 20, 2025.
Dexus Convenience Retail REIT (ASX:DXC) Portfolio Valuation Update
Dexus Convenience Retail REIT reports a $5.4 million valuation uplift, boosting NTA by four cents per security.
Race Oncology Ltd (ASX:RAC) Receives $5.25m R&D Tax Refund
Race Oncology Ltd announces a $5.25 million R&D tax refund to advance clinical development efforts for RC220.